We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NXT:NASDAQNextpower Inc. Analysis

Data as of 2026-06-01 - not real-time

$156.40

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Nextpower Inc. (NXT) is trading at $156.4, comfortably above its 20‑day SMA of 130.36 and near the 30‑day resistance of $163.13, while technicals remain bullish with a RSI of 69.4 and a bullish MACD histogram. The stock exhibits high short‑term volatility (75% 30‑day) and a beta above 2, indicating pronounced sensitivity to market swings. Fundamentally, the company posted a 4.7% YoY revenue decline to $880.5 M in Q1 CY2026, yet beat earnings expectations with non‑GAAP EPS of $1.05, 13.5% above consensus, and forecasts full‑year revenue of $3.95 B, slightly ahead of estimates. Despite a solid operating margin of 18.2% and a strong ROE of 29.6%, the DCF‑derived fair value of $34.3 suggests the current price is markedly overvalued, reflected by a -4.7% upside/downside metric. The balance sheet is robust, featuring $1.15 B in cash against modest debt of $53 M, but the P/B of 10.8 and forward PE of 29 imply premium valuation. Analyst consensus leans “Buy” with a median target of $150, yet the market price already exceeds this, raising concerns of a near‑term pullback. Investors should weigh the strong earnings beat and cash strength against the high valuation, elevated volatility, and sector‑specific risks before deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance and above DCF fair value
  • High volatility and beta increase short‑term uncertainty
  • Recent earnings beat supports stability

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong cash position and low debt
  • Operating margins and ROE remain robust
  • Revenue guidance slightly above analyst estimates

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Solar sector exposure to policy and technology cycles
  • Valuation premium may limit upside
  • Sustainable profitability and cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth-4.70%
Profit Margin16.46%
P/E Ratio40.6
ROE29.57%
ROA12.17%
Debt/Equity2.27
P/B Ratio10.8
Op. Cash Flow$562.9M
Free Cash Flow$311.7M
Industry P/E41.9

Technical Analysis

TrendBullish
RSI69.4
Support$113.08
Resistance$163.13
MA 20$130.36
MA 50$121.76
MA 200$99.40
MACDBullish
VolumeStable
Fear & Greed Index93.27

Valuation

Fair Value$34.29
Target Price$149.00
Upside/Downside-4.73%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.03
Volatility75.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.